Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data
Open Access
- 9 May 2006
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 94 (11), 1759-1760
- https://doi.org/10.1038/sj.bjc.6603161
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancerBritish Journal of Cancer, 2006
- A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancerBritish Journal of Cancer, 2004
- A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancerLung Cancer, 2002
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001
- Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancerEuropean Journal Of Cancer, 2000